UK MHRA grants marketing authorization to sparsentan to treat adult patients with primary immunoglobulin A nephropathy: United Kingdom Wednesday, November 20, 2024, 14:00 Hrs [IST ...

Samsung Biologics said on Wednesday it surpassed the 5 trillion won ($3.59 billion) mark in its accumulated orders this year ...

Detailed price information for Outlook Therapeutics Inc (OTLK-Q) from The Globe and Mail including charting and trades.

Samsung Biologics has secured two deals valued at 930.4 billion won ($668.4 million) with an unnamed European pharmaceutical ...

Novartis has teamed up with Ratio Therapeutics in a $745m licensing and collaboration agreement to advance ...

On Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) presented initial outcomes from the ATTRibute-CM open-label extension (OLE) ...

The fate is uncertain for a proposed high-profile ProKidney Corp. manufacturing plant in Greensboro after the Winston-Salem ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Clinuvel Pharmaceuticals is in advanced discussions with the ...

The spread of scientific misinformation on the social media platform is making the European Centre for Disease Prevention and ...

ImmunityBio (IBRX) announced new data from its ongoing QUILT 3.032 study. As of November, 100 patients with Bacillus Calmette-Guerin, or ...

The upcoming Clinical Trials Supply and Outsourcing in Clinical Trials East Asia conferences will host discussions on supply ...